These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22037290)

  • 21. Safety and pharmacokinetics of XOMA 3AB, a novel mixture of three monoclonal antibodies against botulinum toxin A.
    Nayak SU; Griffiss JM; McKenzie R; Fuchs EJ; Jurao RA; An AT; Ahene A; Tomic M; Hendrix CW; Zenilman JM
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5047-53. PubMed ID: 24913160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of Monoclonal Antibodies in the Sensitive Detection and Neutralization of Botulinum Neurotoxin Serotype B.
    Cheng LW; Henderson TD; Lam TI; Stanker LH
    Toxins (Basel); 2015 Nov; 7(12):5068-78. PubMed ID: 26633496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and Characterization of Monoclonal Antibodies to Botulinum Neurotoxin Type E.
    Bever CS; Scotcher M; Cheng LW; Hnasko RM; Stanker LH
    Toxins (Basel); 2019 Jul; 11(7):. PubMed ID: 31337022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production and characterization of a neutralizing antibody against botulinum neurotoxin A.
    Xiong X; Lv S; Fu C; Li L; Sun Z; Han X; Zhang W
    J Immunol Methods; 2020 Dec; 487():112871. PubMed ID: 33007319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal Antibody Combinations Prevent Serotype A and Serotype B Inhalational Botulism in a Guinea Pig Model.
    Tomic MT; Espinoza Y; Martinez Z; Pham K; Cobb RR; Snow DM; Earnhart CG; Pals T; Syar ES; Niemuth N; Kobs DJ; Farr-Jones S; Marks JD
    Toxins (Basel); 2019 Apr; 11(4):. PubMed ID: 30959899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and partial characterization of high-affinity monoclonal antibodies for botulinum toxin type A and their use in analysis of milk by sandwich ELISA.
    Stanker LH; Merrill P; Scotcher MC; Cheng LW
    J Immunol Methods; 2008 Jul; 336(1):1-8. PubMed ID: 18452945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of botulinum neurotoxin serotypes A and B using a chemiluminescent versus electrochemiluminescent immunoassay in food and serum.
    Cheng LW; Stanker LH
    J Agric Food Chem; 2013 Jan; 61(3):755-60. PubMed ID: 23265581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin.
    Garcia-Rodriguez C; Geren IN; Lou J; Conrad F; Forsyth C; Wen W; Chakraborti S; Zao H; Manzanarez G; Smith TJ; Brown J; Tepp WH; Liu N; Wijesuriya S; Tomic MT; Johnson EA; Smith LA; Marks JD
    Protein Eng Des Sel; 2011 Mar; 24(3):321-31. PubMed ID: 21149386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fully Human Monoclonal Antibodies Effectively Neutralizing Botulinum Neurotoxin Serotype B.
    Matsumura T; Amatsu S; Misaki R; Yutani M; Du A; Kohda T; Fujiyama K; Ikuta K; Fujinaga Y
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32392791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E.
    Baldwin MR; Tepp WH; Pier CL; Bradshaw M; Ho M; Wilson BA; Fritz RB; Johnson EA; Barbieri JT
    Infect Immun; 2005 Oct; 73(10):6998-7005. PubMed ID: 16177380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RBC Adherence of Immune Complexes Containing Botulinum Toxin Improves Neutralization and Macrophage Uptake.
    Al-Saleem FH; Sharma R; Puligedda RD; Elias M; Kattala CD; Simon PM; Simpson LL; Dessain SK
    Toxins (Basel); 2017 May; 9(5):. PubMed ID: 28534855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potent neutralization of botulinum neurotoxin/B by synergistic action of antibodies recognizing protein and ganglioside receptor binding domain.
    Chen C; Wang S; Wang H; Mao X; Zhang T; Ji G; Shi X; Xia T; Lu W; Zhang D; Dai J; Guo Y
    PLoS One; 2012; 7(8):e43845. PubMed ID: 22952786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the epitope region of F1-2 and F1-5, two monoclonal antibodies to Botulinum neurotoxin type A.
    Scotcher MC; Johnson EA; Stanker LH
    Hybridoma (Larchmt); 2009 Oct; 28(5):315-25. PubMed ID: 19857112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced neutralization potency of botulinum neurotoxin antibodies using a red blood cell-targeting fusion protein.
    Adekar SP; Segan AT; Chen C; Bermudez R; Elias MD; Selling BH; Kapadnis BP; Simpson LL; Simon PM; Dessain SK
    PLoS One; 2011 Mar; 6(3):e17491. PubMed ID: 21399689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deletion mutant comprising 198 residues of BoNT/A toxin receptor binding domain retained gt1b binding property but failed to induce protective antibody response in a mouse model.
    Singh MK; Gupta G; Boopathi M; Gupta P; Chauhan V; Tomar A; Singh L; Dhaked RK
    Protein Pept Lett; 2012 May; 19(5):530-7. PubMed ID: 22486648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Monoclonal antibodies to type A, B, E and F botulinum neurotoxins].
    Abbasova SG; Ruddenko NV; Gorokhovatskiĭ AIu; Kapralova MV; Vinogradova ID; Vertiev IuV; Nesmeianov VA; Grishin EV
    Bioorg Khim; 2011; 37(3):344-53. PubMed ID: 21899049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production of serotype C specific and serotype C/D generic monoclonal antibodies using recombinant H(C) and H(N) fragments from Clostridium botulinum neurotoxin types C(1) and D.
    Curran RM; Fringuelli E; Graham D; Elliott CT
    Vet Immunol Immunopathol; 2009 Jul; 130(1-2):1-10. PubMed ID: 19233482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mapping of protective and cross-reactive domains of the type A neurotoxin of Clostridium botulinum.
    Dertzbaugh MT; West MW
    Vaccine; 1996 Nov; 14(16):1538-44. PubMed ID: 9014296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification, potency, and efficacy of the botulinum neurotoxin type A binding domain from Pichia pastoris as a recombinant vaccine candidate.
    Byrne MP; Smith TJ; Montgomery VA; Smith LA
    Infect Immun; 1998 Oct; 66(10):4817-22. PubMed ID: 9746584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of highly sensitive chemiluminescence enzyme immunoassay based on the anti-recombinant H(C) subunit of botulinum neurotoxin type A monoclonal antibodies.
    Liu Z; Song C; Li Y; Liu F; Zhang K; Sun Y; Li H; Wei Y; Xu Z; Zhang C; Yang A; Xu Z; Yang K; Jin B
    Anal Chim Acta; 2012 Jul; 735():23-30. PubMed ID: 22713913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.